ArticleJournal for immunotherapy of cancer2023

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.

Jennifer M Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.